Jefferies Group LLC Seagen Inc. Call Options Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Sep 21, 2023	BUY	$135.27 - $180.11 $919,836 - $1.22 Million	6,800 Added 51.52%	20,000 $2.74 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $919,836 - $1.22 Million	6,800 Added 51.52%	20,000 $2.74 Million
Q2 2022 Sep 21, 2023	SELL	$108.81 - $179.33 $739,908 - $1.22 Million	-6,800 Reduced 34.0%	13,200 $2.34 Million
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $1.44 Million - $2.37 Million	13,200 New	13,200 $2.34 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.